Skip to Content

Ocrelizumab Side Effects

In Summary

Commonly reported side effects of ocrelizumab include: lower respiratory tract infection, upper respiratory tract infection, cough, and infusion related reaction. See below for a comprehensive list of adverse effects.

For the Consumer

Applies to ocrelizumab: intravenous solution

Along with its needed effects, ocrelizumab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking ocrelizumab:

More Common

  • Back pain
  • blurred vision
  • body aches or pain
  • chest tightness
  • chills
  • confusion
  • cough
  • difficulty with breathing
  • dizziness
  • dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
  • ear congestion
  • fast, pounding, or irregular heartbeat or pulse
  • feeling of warmth
  • fever
  • headache
  • hives, itching, or skin rash
  • itching, pain, redness, swelling, tenderness, or warmth on the skin
  • loss of voice
  • nasal congestion
  • nausea and vomiting
  • redness of the face, neck, arms, and occasionally, upper chest
  • runny nose
  • sneezing
  • sore throat
  • sweating
  • trouble breathing
  • unusual tiredness or weakness

Less Common

  • Burning or stinging of the skin
  • painful cold sores or blisters on the lips, nose, eyes, or genitals

Incidence Not Known

  • Convulsions
  • drowsiness

Some side effects of ocrelizumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More Common

  • Bloating or swelling of the face, arms, hands, lower legs, or feet
  • diarrhea
  • discouragement
  • feeling sad or empty
  • irritability
  • lack of appetite
  • loss of interest or pleasure
  • rapid weight gain
  • tingling of the hands or feet
  • trouble concentrating
  • trouble sleeping
  • unusual weight gain or loss

For Healthcare Professionals

Applies to ocrelizumab: intravenous solution


Very common (10% or more): Upper respiratory tract infection (49%), nasopharyngitis (24%), lower respiratory tract infection (10%)

Common (1% to 10%): Bronchitis, cough[Ref]


Common (1% to 10%): Depression[Ref]


Uncommon (0.1% to 1%): Breast cancer[Ref]


Common (1% to 10%): Back pain, pain in extremity[Ref]


Very common (10% or more): Infusion reactions (40%)[Ref]


Common (1% to 10%): Herpes virus associated infections

Frequency not reported: Immunogenicity[Ref]


Very common (10% or more): Neutrophil levels decreased (13%)[Ref]


Very common (10% or more): Skin infections (14%)[Ref]


Common (1% to 10%): Conjunctivitis[Ref]


Common (1% to 10%): Peripheral edema[Ref]


1. "Product Information. Ocrevus (ocrelizumab)." Genentech, South San Francisco, CA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.